Overview
Philip Hopewell is a Pulmonary Medicine provider in San Francisco, California. Dr. Hopewell is highly rated in 1 condition, according to our data. His top areas of expertise are Pulmonary Tuberculosis, Chronic Obstructive Pulmonary Disease (COPD), and Lung Metastases.
His clinical research consists of co-authoring 53 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
1001 Potrero Ave, San Francisco, CA 94110
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Interstitial Lung Disease (ILD) Program
Dr. Paul J. Wolters specializes in the diagnosis and care of patients with interstitial lung disease, a category of disorders in which scarring of lung tissue affects breathing. Wolters is actively involved in research that aims to better understand the development of idiopathic pulmonary fibrosis, a type of interstitial lung disease. He is director of biological research for the UCSF Interstitial Lung Disease Program. Wolters received his medical degree from the University of Minnesota. He completed a residency in internal medicine at the University of Colorado, and a fellowship in pulmonary and critical care medicine at UCSF. He joined UCSF's division of pulmonary and critical care medicine in 1999. Dr. Wolters is highly rated in 12 conditions, according to our data. His top areas of expertise are Acute Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Pulmonary Fibrosis, and Lung Transplant.
University Of California San Francisco
Christopher Ryerson is a Pulmonary Medicine provider in San Francisco, California. Dr. Ryerson is highly rated in 16 conditions, according to our data. His top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Fibrosis, Lung Transplant, and Endoscopy.
Interstitial Lung Disease (ILD) Program
Dr. Laura Koth is a pulmonologist and an expert in interstitial lung disease. She is co-director of UCSF's interstitial lung disease center of excellence. Koth's research activities focus on the mechanisms of lung inflammation and macrophage activation. Macrophages are a type of white blood cell with important roles in immune response. Koth earned her medical degree from Harvard Medical School. She completed residency training in internal medicine at Massachusetts General Hospital, followed by a fellowship in pulmonary and critical care medicine UCSF. She joined the UCSF faculty in 2003. Dr. Koth is highly rated in 12 conditions, according to our data. Her top areas of expertise are Sarcoidosis, Hypersensitivity Pneumonitis, Acute Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, and Lung Transplant.
Frequently Asked Questions about Dr. Philip Hopewell
How do I make an appointment with Dr. Philip Hopewell?
You can book an appointment with Dr. Philip Hopewell by calling their office at 415-206-8314. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Philip Hopewell a top-rated expert for Pulmonary Tuberculosis?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Philip Hopewell is classified as an Advanced expert for Pulmonary Tuberculosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Philip Hopewell specialize in?
While Dr. Philip Hopewell is a Pulmonary Medicine, they have specific expertise in Pulmonary Tuberculosis, Chronic Obstructive Pulmonary Disease (COPD), and Lung Metastases. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pulmonary Medicine.
Does Dr. Philip Hopewell participate in research or clinical trials?
Yes. Dr. Philip Hopewell has published 53 articles and abstracts on conditions like Pulmonary Tuberculosis. You can view a list of Dr. Philip Hopewell's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Pulmonary TuberculosisDr. Hopewell isAdvanced. Learn about Pulmonary Tuberculosis.
- Experienced
- Chronic Obstructive Pulmonary Disease (COPD)
- Lung MetastasesDr. Hopewell isExperienced. Learn about Lung Metastases.